You searched for "screening"

2010 results found

From the editor Nov/Dec 2024

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk Never let it be said that we don’t provide a broad range of topics for you to digest. For...

Identity: does it affect the training experience?

Our identity can be influenced by many factors, both internal and external to ourselves. One may say that if one has not had to consider one’s own identity at any time, perhaps that in itself is a privilege? Equally, one...

Comparing AutoREM accuracy to NAL-NL2 targets: real patient data and simulator verification

A new study examines how accurately AutoREMs from four major brands hit NAL-NL2 targets, revealing strengths, limits and clinical implications. Automatic real ear measurements (AutoREMs) have emerged as a promising way to make hearing aid fittings faster and more consistent....

Easter Weekend sees the start of Innovia Face Visor production

Innovia Medical Group has announced that production of its Innovia Face Visor is now underway.

Patients with severe uncontrolled CRSwNP respond to biologics in the real world

Clinical trials have demonstrated that biologics are effective in treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This multicentre (15 tertiary care centres in France) observational prospective cohort study aims to examine the effectiveness of biologics in treating CRSwNP...

Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms

Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.

KARL STORZ Strengthens its ENT Portfolio with the Acquisition of AventaMed in Ireland

The family-owned medical technology company KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company.

Human immunodeficiency virus and hearing impairment

With an estimated 36.7 million individuals living with HIV / AIDS and literature reporting that these conditions contribute to hearing loss, it is surprising that more focus and resources are not employed to tackle this major hearing health concern. Yolandé...

Public Health Planning for Hearing Impairment (2022)

The World Report on Hearing, published in 2021 by the WHO reports that 430 million people in the world have moderate or worse hearing loss, all of whom require rehabilitation [1]. Over 1.5 billion have any degree of hearing loss....

Planes, trams, and auditoriums: Beware predatory conferencing

Predatory conferences are a growing concern. First highlighted in our sister magazine, Eye News*, the issue affects all areas of medicine – including ENT and audiology. With inboxes filling up with flattering invitations to ‘global’ meetings in glamorous destinations, it’s...

Planes, trams, and auditoriums: Beware predatory conferencing

Predatory conferences are a growing concern. First highlighted in our sister magazine, Eye News*, the issue affects all areas of medicine – including ENT and audiology. With inboxes filling up with flattering invitations to ‘global’ meetings in glamorous destinations, it’s...

Scotland’s first UKAS accreditation for paediatric audiology

The United Kingdom Accreditation Service (UKAS) has granted Scotland’s first accreditation against the Improving Quality In Physiological Services (IQIPS) standard. The award was made to the Audiology Department at NHS Tayside and covers both adult and paediatric audiology services delivered at four hospitals in Dundee, Perth and Brechin.